Register here to receive a copy of our report

Beyond national averages and coverage maps, the real World Cup mobile experience will happen city by city, stadium by stadium.

During FIFA World Cup 2026™, millions of fans will rely on mobile networks to access digital tickets, navigate host cities, share content, stream highlights and stay connected in real time.

In this analysis, MedUX compares mobile Quality of Experience across the 11 U.S. host markets and their stadium areas, showing how connectivity changes from broader city conditions to the places where demand will concentrate.

What’s inside:

• Mobile experience snapshot across the 11 U.S. host markets
• City vs stadium-area comparison for key venues
• Insights on Download speed, Upload speed, 5G access, latency, browsing, social media and streaming start time
• Key examples from stadium areas such as MetLife Stadium, SoFi Stadium, Levi’s Stadium, Mercedes-Benz Stadium and NRG Stadium
• Takeaways for operators, cities and event stakeholders preparing for high-density demand

Register & download the report

Register to access the full analysis

MedUX analyzes how mobile experience changes across the 11 U.S. World Cup 2026 host markets and their associated stadium areas, comparing city-level baselines with the specific venue environments where digital demand will concentrate.

The analysis highlights why World Cup readiness cannot be assessed only through national averages, coverage maps or 5G availability. Real fan experience depends on how networks perform in practical moments: opening digital tickets, sharing content, loading social media, streaming highlights or navigating the city after the match.

If you are interested in understanding how MedUX can support event-area monitoring, stadium connectivity analysis or mobile QoE benchmarking, feel free to reach out to us at hello@medux.com

ALL RIGHTS RESERVED. This article or report has been prepared for the exclusive use and benefit of press media and solely for non-commercial purposes. Press media members are authorized to entirely or partially disseminate, refer, quote, copy, reproduce, distribute, publish and transfer the report and its findings (including all intellectual property rights, data, content graphs and analysis) for information purposes with express attribution to MedUX. Use of the report and its findings, entirely or partially, in any form or by any means, by any other third party or for any other purposes (including, commercial or marketing purposes), without the prior written consent of MedUX, is strictly prohibited. Operators can make a request to MedUX for a license to use quality or certification seals, as well as marketing rights to quote the findings. Non-authorized use will be considered a violation of copyright and trademarks laws.